Announcements Trials

Browse Landscape

Phase

Status

Recruiting 2 Unknown 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 6 Neoplasms 5 Small Cell Lung Carcinoma 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Breast Neoplasms 2 Advanced Cancer 2 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Stomach Neoplasms 1 Stereotactic Body Radiation Therapy 1 Sarcoma 1 Recurrence 1 Platinum-resistant Recurrent Clear Cell Ovarian Cancer 1 Pheochromocytoma 1 Paraganglioma, Extra-Adrenal 1 Paraganglioma 1 Pancreatic Neoplasms 1 NSCLC 1 Lung Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Colonic Neoplasms 1 Carcinoma, Medullary 1 Brain Neoplasms 1 Advanced Solid Tumors 1 Advanced Malignancy 1 Advanced Endometrial Cancer 1 Adenocarcinoma of Lung 1

Interventions

Gemcitabine 358 Fluorouracil 94 Oxaliplatin 81 Capecitabine 74 130-nm albumin-bound paclitaxel 71 Albumin-Bound Paclitaxel 70 Radiotherapy 67 Leucovorin 58 Irinotecan 49 Erlotinib Hydrochloride 47 Cisplatin 44 Bevacizumab 31 pembrolizumab 30 Radiosurgery 30 Docetaxel 26 Taxes 24 Nivolumab 24 Cetuximab 24 Pancreaticoduodenectomy 20 Drug Therapy 17 folfirinox 16 Cyclophosphamide 16 Radiation 15 Ipilimumab 13 Endoscopic Ultrasound-Guided Fine Needle Aspiration 13 Surgical Procedures, Operative 12 Sorafenib 12 Paclitaxel 12 Neoadjuvant Therapy 12 irinotecan sucrosofate 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Neoplasms × anlotinib × Clear all

NCT05493995 2024-05-09

PAAG

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Completed

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡